Related Experiment Videos
Correlation between MIB-1 staining indices and recurrence in low-grade astrocytomas
M Hoshi1, K Yoshida, K Shimazaki
1Department of Neurosurgery, School of Medicine Keio University, Tokyo, Japan. mhoshi@med.keio.ac.jp
Abstract:
Although low-grade astrocytomas are histologically benign, some of them recur frequently. We retrospectively investigated the relationship between MIB-1 staining index (SI) and recurrence in 47 low-grade astrocytomas that were treated in Keio University Hospital from 1981 to 1991. We found a correlation between SI and recurrence. MIB-1 SIs recurrent low-grade astrocytomas have been shown to be almost similar to those of astrocytoma grade 3. We concluded that it was very important to examine MIB-1 SI in all astrocytomas especially in low-grade astrocytomas, because MIB-1 SI is one of the factors from which we could predict-recurrence and decide whether radiotherapy or chemotherapy should be performed.
Insights
Low-grade astrocytomas can recur, but MIB-1 staining index (SI) can predict recurrence. Higher MIB-1 SI in low-grade astrocytomas indicates a higher risk, guiding treatment decisions like radiotherapy or chemotherapy.
Area of Science:
- Neuro-oncology
- Pathology
- Cancer Research
Background:
- Low-grade astrocytomas are histologically benign but prone to recurrence.
- Predicting recurrence in these tumors is crucial for effective treatment planning.
Purpose of the Study:
- To investigate the correlation between MIB-1 staining index (SI) and tumor recurrence in low-grade astrocytomas.
- To evaluate the utility of MIB-1 SI as a prognostic marker for astrocytoma recurrence.
Main Methods:
- Retrospective analysis of 47 low-grade astrocytoma cases treated between 1981 and 1991.
- Assessment of MIB-1 staining index (SI) in tumor samples.
Main Results:
- A significant correlation was found between MIB-1 SI and tumor recurrence.
- MIB-1 SI in recurrent low-grade astrocytomas was comparable to that of grade 3 astrocytomas.
Conclusions:
- MIB-1 SI is an important factor for predicting recurrence in low-grade astrocytomas.
- Evaluating MIB-1 SI is essential for guiding therapeutic decisions, including radiotherapy and chemotherapy.